Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Scientists create new microparticles that self-assemble like atoms into molecules

Scientists have created new kinds of particles, 1/100th the diameter of a human hair, that spontaneously assemble themselves into structures resembling molecules made from atoms. These new particles come together, or "self-assemble," to form structures in patterns that were previously impossible to make and hold promise for manufacturing advanced optical materials and ceramics.

1 Nov 2012

FDA: Ameridose voluntarily recalls all unexpired drug products in circulation

The U.S. Food and Drug Administration announced today that Ameridose, LLC, based in Westborough, Mass., is voluntarily recalling all of its unexpired products in circulation.

1 Nov 2012

Powered exoskeleton provides more independence to people with severe spinal cord injuries

The dream of regaining the ability to stand up and walk has come closer to reality for people paralyzed below the waist who thought they would never take another step.

31 Oct 2012

Bayer HealthCare signs merger agreement to acquire Schiff Nutrition International

Bayer HealthCare LLC has signed a merger agreement to acquire Schiff Nutrition International, Inc., a leading company offering vitamins and nutritional supplements in the United States and other countries.

30 Oct 2012

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Today, mothers in Africa sometimes walk more than 10 miles to a clinic only to learn that conventional HIV test results for their babies are not available yet.

29 Oct 2012

Scientists develop new prototype ultra sensitive disease sensor

Scientists have developed a prototype ultra-sensitive sensor that would enable doctors to detect the early stages of diseases and viruses with the naked eye, according to research published today in the journal Nature Nanotechnology.

29 Oct 2012

Viewpoints: Washington Post endorses Obama; GOP Senate candidates hurting party's reach to women; 'Too much choice' in Medicare?

Mr. Obama is committed to the only approach that can succeed: a balance of entitlement reform and revenue increases. Mr. Romney, by contrast, has embraced his party's reality-defying ideology that taxes can always go down but may never go up. Along that road lies a future in which interest payments crowd out everything else a government should do, from defending the nation to caring for its poor and sick to investing in its children.

29 Oct 2012

Exploring the New Biopharmaceutical Contract Manufacturing Offering from Olympus

In this interview, News-Medical talks to Peter Gariepy, to find out about the new Contract Manufacturing Offering (CMO) from Olympus Life Science Solutions.

From Evident Corporation - Life Sciences 25 Oct 2012

BioInterface 2012 starts today at University College Dublin, Ireland

BioInterface 2012, a major international medical device conference by the US-based Surfaces in Biomaterials Foundation, starts today at University College Dublin, Ireland and runs until Thursday 25 October.

From Medtronic 24 Oct 2012

U.S. Marshals seize dietary supplements and unapproved drugs from Confidence

At the request of the U.S. Food and Drug Administration, U.S. Marshals recently seized dietary supplements and unapproved drugs from Confidence, Inc., of Port Washington, N.Y.

24 Oct 2012

Derma Sciences to initiate DSC127 Phase 3 program in diabetic foot ulcers

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported that based on a meeting held last week with the U.S. Food and Drug Administration (FDA), the Company plans to begin its Phase 3 program in December 2012 in support of a New Drug Application (NDA) for DSC127 for treatment of diabetic foot ulcers.

23 Oct 2012

Financial environment presents opportunities as well as challenges

Leading biotechnology executive Dr Deborah Rathjen has called on the industry to look at the opportunities that exist in a post-GFC environment, not just to focus on the negatives.

23 Oct 2012

Pfizer announces intention to acquire NextWave

Pfizer Inc. today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related central nervous system (CNS) disorders.

23 Oct 2012

Viewpoints: LA Times endorses Obama; Romney, Ryan 'obfuscating their plans for Medicare, Medicaid;' Obama's health law polarizes the country

The outcome of the presidential election will determine which of two opposing paths the nation will follow on health care for all Americans. If voters re-elect President Obama, he will protect the health care reforms.

23 Oct 2012

Lantheus Medical Imaging extends contract to supply molybdenum-99 to Nordion

Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that it has extended its contract with Nordion to supply molybdenum-99 (Mo-99) for use in its TechneLite (Technetium Tc 99m Generator) generators. Mo-99 is the parent isotope of technetium-99m (Tc-99m), the medical radioisotope most widely used in nuclear medicine diagnostic imaging tests.

22 Oct 2012

Lean principles help improve stroke treatment at Barnes-Jewish Hospital

A process developed to increase efficiency and productivity in Japanese car factories has helped improve stroke treatment at Barnes-Jewish Hospital, report researchers at Washington University School of Medicine in St. Louis.

20 Oct 2012

EMA CHMP issues positive opinion to Savient's KRYSTEXXA for treatment of chronic gout

Savient Pharmaceuticals, Inc. and its wholly owned subsidiary, Savient Pharma Ireland Limited, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has completed its scientific assessment and has issued a positive opinion recommending approval of a marketing authorization in the European Union for KRYSTEXXA for the treatment of severe debilitating chronic tophaceous gout in adult patients who may also have erosive joint involvement and who have failed to normalize serum uric acid with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these medicines are contraindicated.

19 Oct 2012

BioResearch Open Access explores Cell-SELEX technology

SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.

19 Oct 2012

Physicians urged to think twice before they prescribe compounded drugs

The recent outbreak of meningitis in the US-and the subsequent deaths of 15 individuals-has renewed scrutiny on the contemporary practice of pharmacy compounding. The risks to patients, and associated liability risk to prescribing physicians, largely outweigh the benefits when the practice goes beyond the traditional, extemporaneous role, according to Sarah Sellers from q-Vigilance LLC and Wulf Utian from Case Western Reserve University in the US. Sellers and Utian's opinion piece appears online in the journal Drugs, published by Adis.

16 Oct 2012

Bruker launches robust ContourGT-I 3D Optical Microscope

Bruker announced the launch today of the ContourGT-I 3D Optical Microscope to enhance R&D productivity and maximize manufacturing throughput for industrial applications. The ContourGT-I has been optimized to accelerate and simplify measurement setup and feature-tracking and is the world's first bench top profiling system to incorporate Bruker's proprietary tip/tilt head design, along with fully automated functionality, including turret, lenses, and illumination.

From Bruker Nano Surfaces and Metrology 15 Oct 2012

Manufacturing News and Research

Further Reading

Scientists create new microparticles that self-assemble like atoms into molecules

FDA: Ameridose voluntarily recalls all unexpired drug products in circulation

Powered exoskeleton provides more independence to people with severe spinal cord injuries

Bayer HealthCare signs merger agreement to acquire Schiff Nutrition International

New HIV test for babies differs from conventional test, delivers diagnosis in less than an hour

Scientists develop new prototype ultra sensitive disease sensor

Viewpoints: Washington Post endorses Obama; GOP Senate candidates hurting party's reach to women; 'Too much choice' in Medicare?

Exploring the New Biopharmaceutical Contract Manufacturing Offering from Olympus

BioInterface 2012 starts today at University College Dublin, Ireland

U.S. Marshals seize dietary supplements and unapproved drugs from Confidence

Derma Sciences to initiate DSC127 Phase 3 program in diabetic foot ulcers

Financial environment presents opportunities as well as challenges

Pfizer announces intention to acquire NextWave

Viewpoints: LA Times endorses Obama; Romney, Ryan 'obfuscating their plans for Medicare, Medicaid;' Obama's health law polarizes the country

Lantheus Medical Imaging extends contract to supply molybdenum-99 to Nordion

Lean principles help improve stroke treatment at Barnes-Jewish Hospital

EMA CHMP issues positive opinion to Savient's KRYSTEXXA for treatment of chronic gout

BioResearch Open Access explores Cell-SELEX technology

Physicians urged to think twice before they prescribe compounded drugs

Bruker launches robust ContourGT-I 3D Optical Microscope

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News